勁嘉股份(002191.SZ)漲超8% 近10日北上資金增持明顯
格隆匯12月6日丨此前橫盤整理的勁嘉股份(002191.SZ)今日放量上漲,收報11.79元,漲8.26%,成交6.68億元,最新總市值173億元。天風證券近日點評稱,公司在穩步發展煙標主業的基礎上,其彩盒包裝、新型煙草業務頗具看點,並給予買入評級。盤面上,近10個交易日該股處於橫盤整理階段,但查看北上資金流入數據發現,近10日北上資金增持明顯,持股比例由11月21日的1.34%升至12月5日的3.02%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.